Lassman, A. B. (20. maj 2009). "Retrospective analysis of outcomes among more than 1,000 patients with newly diagnosed anaplastic oligodendroglial tumors". Journal of Clinical Oncology. 27 (15S): 2014. doi:10.1200/jco.2009.27.15_suppl.2014. ISSN0732-183X.
Sunyach MP, Jouvet A, Perol D, et al. (december 2007). "Role of exclusive chemotherapy as first line treatment in oligodendroglioma". J. Neurooncol. 85 (3): 319-28. doi:10.1007/s11060-007-9422-3. PMID17568995.
Mohile NA, Forsyth P, Stewart D, et al. (september 2008). "A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis". J. Neurooncol. 89 (2): 187-93. doi:10.1007/s11060-008-9603-8. PMID18458821.
Sunyach MP, Jouvet A, Perol D, et al. (december 2007). "Role of exclusive chemotherapy as first line treatment in oligodendroglioma". J. Neurooncol. 85 (3): 319-28. doi:10.1007/s11060-007-9422-3. PMID17568995.
Mohile NA, Forsyth P, Stewart D, et al. (september 2008). "A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis". J. Neurooncol. 89 (2): 187-93. doi:10.1007/s11060-008-9603-8. PMID18458821.
Lassman, A. B. (20. maj 2009). "Retrospective analysis of outcomes among more than 1,000 patients with newly diagnosed anaplastic oligodendroglial tumors". Journal of Clinical Oncology. 27 (15S): 2014. doi:10.1200/jco.2009.27.15_suppl.2014. ISSN0732-183X.